Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1946 1
1949 1
1961 1
1963 1
1983 2
1991 2
1992 1
1994 2
1995 1
1996 4
1997 4
1998 5
1999 5
2000 8
2001 13
2002 5
2003 8
2004 17
2005 25
2006 43
2007 64
2008 46
2009 83
2010 95
2011 202
2012 249
2013 290
2014 363
2015 457
2016 392
2017 406
2018 314
2019 315
2020 425
2021 432
2022 379
2023 357
2024 442
2025 144

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

4,729 results

Results by year

Filters applied: . Clear all
Page 1
Age-Related Macular Degeneration: A Review.
Fleckenstein M, Schmitz-Valckenberg S, Chakravarthy U. Fleckenstein M, et al. JAMA. 2024 Jan 9;331(2):147-157. doi: 10.1001/jama.2023.26074. JAMA. 2024. PMID: 38193957 Review.
IMPORTANCE: Age-related macular degeneration (AMD) affects approximately 20 million people in the US and 196 million people worldwide. ...AMD occurs when extracellular deposits accumulate in the outer retina, ultimately leading to photoreceptor degeneration a …
IMPORTANCE: Age-related macular degeneration (AMD) affects approximately 20 million people in the US and 196 million people wo …
Development of Macular Atrophy in Patients with Wet Age-Related Macular Degeneration Receiving Anti-VEGF Treatment.
Foss A, Rotsos T, Empeslidis T, Chong V. Foss A, et al. Ophthalmologica. 2022;245(3):204-217. doi: 10.1159/000520171. Epub 2021 Oct 25. Ophthalmologica. 2022. PMID: 34695835 Free article. Review.
Age-related macular degeneration (AMD) is a leading cause of blindness. Late AMD can be classified into exudative (commonly known as wet AMD [wAMD]) or dry AMD, both of which may progress to macular atrophy (MA). ...For example, excessive blockade of V …
Age-related macular degeneration (AMD) is a leading cause of blindness. Late AMD can be classified into exudative (commonly kn …
Cataract Surgery in Patients With Wet Macular Degeneration.
Ober MD, Fine HF, Saraf SS. Ober MD, et al. Ophthalmic Surg Lasers Imaging Retina. 2017 Sep 1;48(9):700-704. doi: 10.3928/23258160-20170829-03. Ophthalmic Surg Lasers Imaging Retina. 2017. PMID: 28902329 Review. No abstract available.
Emerging roles of transforming growth factor beta signaling in wet age-related macular degeneration.
Wang K, Li H, Sun R, Liu C, Luo Y, Fu S, Ying Y. Wang K, et al. Acta Biochim Biophys Sin (Shanghai). 2019 Jan 1;51(1):1-8. doi: 10.1093/abbs/gmy145. Acta Biochim Biophys Sin (Shanghai). 2019. PMID: 30496406 Free article. Review.
Age-related macular degeneration (AMD) is one of the major causes of irreversible blindness among aging populations in developed countries and can be classified as dry or wet according to its progression. ...These remarkable findings indicate that TGF-beta si …
Age-related macular degeneration (AMD) is one of the major causes of irreversible blindness among aging populations in develop …
Risk factors for wet macular degeneration: a systematic review, with novel insights from the Scottish Heart Health Extended Cohort.
Fitton CA, Quigley MMR, Belch JJF. Fitton CA, et al. BMC Ophthalmol. 2025 Feb 10;25(1):67. doi: 10.1186/s12886-025-03868-5. BMC Ophthalmol. 2025. PMID: 39930367 Free PMC article.
BACKGROUND: Age-related macular degeneration (AMD) is a major cause of vision loss worldwide. This study aimed to assess risk factors for wet AMD by two methods: assessing risk factors measured in the Scottish Heart Health Extended Cohort (SHHEC), and to syst …
BACKGROUND: Age-related macular degeneration (AMD) is a major cause of vision loss worldwide. This study aimed to assess risk …
Associations between the Complement System and Choroidal Neovascularization in Wet Age-Related Macular Degeneration.
Jensen EG, Jakobsen TS, Thiel S, Askou AL, Corydon TJ. Jensen EG, et al. Int J Mol Sci. 2020 Dec 21;21(24):9752. doi: 10.3390/ijms21249752. Int J Mol Sci. 2020. PMID: 33371261 Free PMC article. Review.
Age-related macular degeneration (AMD) is the leading cause of blindness affecting the elderly in the Western world. The most severe form of AMD, wet AMD (wAMD), is characterized by choroidal neovascularization (CNV) and acute vision loss. ...
Age-related macular degeneration (AMD) is the leading cause of blindness affecting the elderly in the Western world. The most …
Clinical efficacy and safety of ranibizumab in the treatment of wet age-related macular degeneration.
Ferro Desideri L, Barra F, Ferrero S, Traverso CE, Nicolò M. Ferro Desideri L, et al. Expert Opin Biol Ther. 2019 Aug;19(8):735-751. doi: 10.1080/14712598.2019.1627322. Epub 2019 Jun 13. Expert Opin Biol Ther. 2019. PMID: 31180279 Review.
Introduction: Although several approaches have been studied for treating wet age-related macular degeneration (w-AMD), currently, the most effective strategy in the management of this visual disorder is represented by anti-VEGF drugs. ...RBZ is a humanized, r …
Introduction: Although several approaches have been studied for treating wet age-related macular degeneration (w-AMD), …
Abicipar pegol: an investigational anti-VEGF agent for the treatment of wet age-related macular degeneration.
Ferro Desideri L, Traverso CE, Nicolò M. Ferro Desideri L, et al. Expert Opin Investig Drugs. 2020 Jul;29(7):651-658. doi: 10.1080/13543784.2020.1772754. Epub 2020 Jun 1. Expert Opin Investig Drugs. 2020. PMID: 32479126 Review.
INTRODUCTION: Several approaches have been investigated for the management of wet age-related macular degeneration (w-AMD); however, the first-line treatment option for w-AMD currently constitutes anti-VEGF agents. ...
INTRODUCTION: Several approaches have been investigated for the management of wet age-related macular degeneration (w-A …
A Randomized Controlled Trial of OPT-302, a VEGF-C/D Inhibitor for Neovascular Age-Related Macular Degeneration.
Jackson TL, Slakter J, Buyse M, Wang K, Dugel PU, Wykoff CC, Boyer DS, Gerometta M, Baldwin ME, Price CF; Opthea Study Group Investigators. Jackson TL, et al. Ophthalmology. 2023 Jun;130(6):588-597. doi: 10.1016/j.ophtha.2023.02.001. Epub 2023 Feb 6. Ophthalmology. 2023. PMID: 36754174 Free article. Clinical Trial.
PURPOSE: Neovascular (wet) age-related macular degeneration (nAMD) is driven by VEGFs A, C, and D, which promote angiogenesis and vascular permeability. ...
PURPOSE: Neovascular (wet) age-related macular degeneration (nAMD) is driven by VEGFs A, C, and D, which promote angiog …
Guidelines for the management of neovascular age-related macular degeneration by the European Society of Retina Specialists (EURETINA).
Schmidt-Erfurth U, Chong V, Loewenstein A, Larsen M, Souied E, Schlingemann R, Eldem B, Monés J, Richard G, Bandello F; European Society of Retina Specialists. Schmidt-Erfurth U, et al. Br J Ophthalmol. 2014 Sep;98(9):1144-67. doi: 10.1136/bjophthalmol-2014-305702. Br J Ophthalmol. 2014. PMID: 25136079 Free PMC article. Review.
Age-related macular degeneration (AMD) is still referred to as the leading cause of severe and irreversible visual loss world-wide. ...
Age-related macular degeneration (AMD) is still referred to as the leading cause of severe and irreversible visual loss world- …
4,729 results

Searches related to "wet macular degeneration"